Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus: A clue to the explanation of the results of the BARI study

Journal of the American College of Cardiology

Volumn 30, Issue 6, 1997, Pages 1420-1425

  Rozenman, Yoseph ^a   Sapoznikov, Dan ^a   Mosseri, Morris ^a   Gilon, Dan ^a   Lotan, Chaim ^a   Nassar, Hisham ^a   Weiss, A Teddy ^a   Hasin, Yonathan ^a   Gotsman, Mervyn S ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DISEASE COURSE; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DIABETES COMPLICATIONS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0030725382     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00342-2     Document Type: Article

References (29)

1. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996;335:217-25.
2. CABRI Trial Participants. First year results of CABRI (Coronary Angioplasty versus Bypass Revascularization Investigation). Lancet 1995;346: 1184-9.
3. RITA Trial Participants. Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial. Lancet 1993;341:573-80.
4. Weintraub WS, Mauldin PD, Becker E, Kosinski AS, King SB III. A comparison of the costs and quality of life after coronary angioplasty or coronary surgery for multivessel coronary artery disease: results from the Emory Angioplasty Versus Surgery Trial (EAST). Circulation 1995;92:2831-40.
5. Hamm CW, Reimers J, Ischinger T, Rupprecht HJ, Berger J, Bleifeld W. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. N Engl J Med 1994;331:1037-43.
6. Pocock SJ, Henderson RA, Rickards AF et al. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet 1995;346: 1184-9.
7. Ferguson JJ. NHLBI BARI clinical alert on diabetics treated with angioplasty [news]. Circulation 1995;92:3371.
8. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 1993;16:434-44.
9. Uusitupa MIJ, Niskanen LK, Sitonen O, Voutilainen E, Pyorala K. 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and non-diabetic subjects. Circulation 1990; 82:27-36.
10. Brandrup-Wognsen G, Haglid M, Karlsonn T, Berggren H, Herlitz BJ. Preoperative risk indicators of death at an early and late stage after coronary artery bypass grafting. Thorac Cardiovasc Surg 1995;43:77-82.
11. Sergeant P, Lesaffre E, Flameng W, Suy R, Blackstone E. The return of clinically evident ischemia after coronary artery bypass grafting. Eur J Cardiothorac Surg 1991;5:447-57.
12. Stein B, Weintraub WS, Gebhart SPG, Cohen-Bernstein MN, et al. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 1995;91:979-89.
13. Rozenman Y, Gilon D, Welber S, Sapoznikov D, Gotsman MS. Clinical and angiographic predictors of immediate recoil after successful coronary angioplasty and relation to late restenosis. Am J Cardiol 1993;72:1020-5.
14. Rozenman Y, Gilon D, Welber S, et al. Influence of coronary angioplasty on the progression of coronary atherosclerosis. Am J Cardiol 1995;76: 1126-30.
15. Lichtlen PR, Nikutta P, Jost S, Deckers J, Wiese B, Rafflenbeul W. Anatomical progression of coronary artery disease in humans as seen by prospective, repeated, quantitated coronary angiography: relation to clinical events and risk factors. Circulation 1992;86:828-38.
16. Robertson W, Strong J. Atherosclerosis in patients with hypertension and diabetes mellitus. Lab Invest 1968;18:538-51.
17. Waller B, Palumbo R, Roberts WC. Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 years. Am J Med 1980;69:498-506.
18. Myler RK, Topol EJ, Shaw RE, et al. Multiple vessel coronary angioplasty: classification, results, and patterns of restenosis in 494 consecutive patients. Cathet Cardiovasc Diagn 1987;13:1-15.
19. Quigley PJ, Hlatky MA, Hinohara T, et al. Repeat percutaneous transluminal coronary angioplasty and predictors of recurrent stenosis. Am J Cardiol 1989;63:409-13.
20. Lambert M, Bonan R, Cote G, et al. Multiple coronary angioplasty: a model to discriminate systemic and procedural factors related to restenosis. J Am Coll Cardiol 1988;12:310-4.
21. Weintraub WS, Kosinski AS, Brown CL III, King SB III. Can restenosis after coronary angioplasty be predicted from clinical variables? J Am Coll Cardiol 1993;21:6-14.
22. Macdonald RG, Henderson MA, Hirshfeld JW Jr, et al. for the M-HEART group. Patient related variables and restenosis after percutaneous transluminal coronary angioplasty: a report from the M-HEART group. Am J Cardiol 1990;66:926-41.
23. Bourassa MG, Lesperance J, Eastwood C, et al. Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1991;18:368-76.
24. Rozenman Y, Gilon D, Welber S, et al. Total coronary artery occlusion later than one month after successful transluminal angioplasty: incidence and clinical presentation. Cardiology 1994;85:222-8.
25. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (first of two parts). New Engl J Med 1991;326:242-50.
26. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (second of two parts). New Engl J Med 1991;326:310-8.
27. Ledet T, Fisher-Dzoga K, Wissler RW. Growth of rabbit aortic smooth muscle cells cultured in diabetic and hyperlipemic serum. Diabetes 1976;25: 207-15.
28. Banskota NK, Taub R, Zellner K, Olsen P, King GL. Characterization of induction of protooncogene c-myc and cellular growth in human vascular smooth muscle cells in insulin and IGF-1. Diabetes 1989;38:123-9.
29. Campeau L, Enjalbert M, Lesperance J, et al. The relationship of risk factors to the development of atherosclerosis in saphenous vein bypass grafts and the progression of disease in the native circulation. N Engl J Med 1984;311: 1329-32.